These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 356622)

  • 1. The thymus in patients with allogeneic bone marrow transplants.
    Beschorner WE; Hutchins GM; Elfenbein GJ; Santos GW
    Am J Pathol; 1978 Jul; 92(1):173-86. PubMed ID: 356622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bone marrow transplantation for severe aplastic anemia and leukemia. Two years experience with 31 patients in Zagreb (Yugoslavia).
    Labar B; Bogdanic V; Kastelan A; Vrtar M; Grgic-Markulin L; Balabanic-Kamauf B; Francetic I; Dobric I; Grgicevic D; Kerhin-Brkljacic V
    Biomed Pharmacother; 1986; 40(9):332-7. PubMed ID: 3548836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants.
    Trigg ME; Billing R; Sondel PM; Exten R; Hong R; Bozdech MJ; Horowitz SD; Finlay JL; Moen R; Longo W
    Cancer Treat Rep; 1985 Apr; 69(4):377-86. PubMed ID: 3888387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation at Christchurch 1979-1985.
    Heslop HE; Heaton DC; Hart DN; Allen JR; Abbott GD; Beard ME
    N Z Med J; 1986 May; 99(801):318-21. PubMed ID: 3520412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation in Canada.
    Buskard NA
    Can Med Assoc J; 1980 Jul; 123(1):19-22. PubMed ID: 6998551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.
    Santos GW; Sensenbrenner LL; Anderson PN; Burke PJ; Klein DL; Slavin RE; Schacter B; Borgaonkar DS
    Transplant Proc; 1976 Dec; 8(4):607-10. PubMed ID: 11591
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with second marrow transplants.
    Wright SE; Thomas ED; Buckner CD; Clift RA; Fefer A; Neiman PE; Storb R
    Exp Hematol; 1976 Jul; 4(4):221-6. PubMed ID: 782896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.
    Oblon DJ; Weiner RS; Mackin PJ
    J Fla Med Assoc; 1984 May; 71(5):329-35. PubMed ID: 6376696
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation in children: Tokai experience 1982 to 1984.
    Kato S; Hoshi N; Nagasaka M; Muranaka S; Yabe H; Kimura M
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):147-58. PubMed ID: 3010509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation for leukemia and aplastic anemia.
    Thomas ED; Buckner CD; Cheever MA; Clift RA; Einstein AB; Fefer A; Neiman PE; Sanders J; Storb R; Weiden PL
    Transplant Proc; 1976 Dec; 8(4):603-5. PubMed ID: 11590
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation.
    Dermime S; Mavroudis D; Jiang YZ; Hensel N; Molldrem J; Barrett AJ
    Bone Marrow Transplant; 1997 May; 19(10):989-99. PubMed ID: 9169643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow grafting in patients with acute leukemia.
    Thomas ED; Buckner CD; Clift RA; Fass L; Fefer A; Lerner KG; Neiman P; Rowley N; Storb R
    Transplant Proc; 1973 Mar; 5(1):917-22. PubMed ID: 4144473
    [No Abstract]   [Full Text] [Related]  

  • 18. Marrow transplants in aplastic anemia and leukemia.
    Fefer A; Thomas ED; Buckner CD; Storb R; Neiman P; Glucksberg H; Clift RA; Lerner KG
    Semin Hematol; 1974 Jul; 11(3):353-67. PubMed ID: 4151983
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bone marrow transplantation in cancer patients].
    Morishima Y
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2922-9. PubMed ID: 3532958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ABO incompatibility in allogeneic bone marrow transplantation].
    Quabeck K; Beelen DW; Mahmoud HK; Schaefer UW; Schmidt CG; Henneberg-Quester KB; Luboldt W
    Beitr Infusionther Klin Ernahr; 1987; 18():310-5. PubMed ID: 3326589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.